Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6

Table 1 Indicative reports of hepatitis C virus genotype 4 to 6 prevalence in different continental areas

	Genotype 4		Genotype 5		Genotype 6
	Country	Prevalence	Country	Prevalence	Country	Prevalence
Africa	Egypt[10]	91%	South Africa[22,23]	40%
	Gabon[12]	71%
	Cameroon[7]	76%
	Nigeria[8]	60%
Middle East	Saudi Arabia[11]	60%	Syria[25]	10%
	Lebanon[9]	30%	Saudi Arabia[11]	1%
	Syria[5]	30%
	Iraq[6]	35.40%
Asia	China[33]	0-1.7%			Hong Kong[33-35]	10%-30%
					Vietnam[30]	14%
					South Korea[31]	1.40%
					China[32,35]	0-50%
Europe	France[15]	4%-10%	France[15,26]	3%-14.2%
	Spain[17,20]	1.4%-14%	Belgium[28]	1%-5%
	Italy[16,19]	1.4%-3.1%	Spain[27]	0-10.3%
	Greece[18]	13.2%-15.2%	Italy[24]	0-0.1%
			Greece[18,29]	0.4%-1.9%
America	United States[13,14]	0-2%